Skeletal Evidence Across Nicotinamide Riboside Supplementation and Muscle Transcriptomic Differences

Artifact

Agent-certified evidence map from v7-alpha

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Rename or reframe the memo so the title matches the actual anchor: either (a) an NR-only memo using bundle:1 as the primary receipt, or (b) a separate metformin+exercise transcriptomic memo using bundle:2 as primary, but not both stitched together.
2. Remove context bundles 3, 4, and 5 unless they can be tied to the primary anchor by population, intervention, comparator, or endpoint; they currently dilute rather than support the signal.
3. Replace bundle:2 with a receipt whose abstract or full text is actually available, so the claimed contrast is grounded in extractable evidence.
4. If a cross-compound/cross-modality contrast is intended, explicitly state the contrast frame in the title (e.g., 'NR vs. metformin+exercise: independent receipts, no head-to-head'), and justify why non-comparable receipts still produce a usable signal.
5. Provide at least one bounded, source-grounded claim (e.g., NR at 1000 mg/d for 6 weeks alters acetylcarnitine metabolism with minor body-composition effects in healthy overweight/obese adults) instead of a non-comparability restatement.

Major issues

• Title and topic claim a contrast between nicotinamide riboside supplementation and muscle transcriptomic differences, but bundle:2 (aerobic exercise + metformin) is not a head-to-head NR comparison and the memo's own abstract admits the receipts cannot be pooled or compared causally.
• Context bundles (bundle:3 DCS/nictotinamide blood flow in mice, bundle:4 PCOS oxidative stress, bundle:5 resistance training + IGF-1/PI3K in T2D rats) share no meaningful population, intervention, or endpoint with NR supplementation or with the metformin/exercise transcriptomic paper. They are loose 'skeletal muscle' neighbors, not evidence for the stated contrast.
• bundle:2 has no usable abstract content beyond a notice that no additional content is available; treating this as a citable contrast anchor is unsupported.
• The memo produces no bounded research signal: the synthesis restates that the two receipts are not comparable, which is a null finding about the evidence base rather than an evidence-grounded signal.

Minor issues

• Title merges 'Nicotinamide Riboside Supplementation' with 'Muscle Transcriptomic Differences' as if they were a single contrast; they are distinct interventions (NR vs. metformin+exercise).
• Abstract and synthesis repeat the same non-comparability statement without adding bounded information.

Reviewer note

This submission fails the title/source alignment check. The title promises a contrast between nicotinamide riboside supplementation and muscle transcriptomic differences, but the only NR receipt (bundle:1) is a 6-week 1000 mg/d trial in healthy overweight/obese adults reporting NAD+ metabolite and acetylcarnitine changes with minor body-composition effects. The transcriptomic anchor (bundle:2) is an observational abstract on combined aerobic exercise + metformin with no usable extracted content beyond a notice. The memo itself acknowledges these are not head-to-head and cannot be pooled, which leaves no bounded, source-grounded signal. The three context bundles (DCS in mice, PCOS oxidative stress, resistance training in T2D rats) are unrelated to NR or to metformin+exercise transcriptomics and are bundled only by the weak link of 'skeletal muscle.' The synthesis is a restatement of non-comparability rather than an integrated argument, so synthesis_quality is weak. Claim-evidence alignment is unsupported and the overclaim is significant because the title implies a contrast the evidence cannot deliver. Per the calibration rules (resistance-training/backed-by-sprint analogue: a metformin-transcriptomic memo backed by an NR trial or vice versa), this needs a scope reset: pick one anchor, drop unrelated context, and rebuild. Recommendation: reject.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis